Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

May 14, 2019 / 08:00AM GMT
Release Date Price: $17.92 (-8.06%)
Operator

Thank you very much For participating today's financial announcement for fiscal 2018 here at Takeda despite your busy schedule. (Operator Instructions) Let me introduce today's presenters. Presenting CEO, Christophe Weber; Research and Development President, Andy Plump; Chief Financial Officer, Costa Saroukos. And for the Q&A session, we invite Deputy President, Masato Iwasaki; and Plasma-derived Therapies Business Unit President, Julie Kim.

After the -- all the presentation finished, we would like to take your questions. And there are some announcements before the presentation. What we are going to present from now on needs to be confirmed with the indemnifications in this slide. Now we would like to have Christophe's presentation.

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

(foreign language). Good afternoon. Thank you very much for joining us today. I know it's already the announcement, or year-end result announcement time, so you are very busy with many companies providing their result.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot